Wolverine Trading, LLC Adamis Pharmaceuticals Corp Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $8,053 - $10,689	-14,643 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.23 $8,346 - $18,010	14,643 New	14,643 $9,000
Q3 2019 Nov 14, 2019	SELL	$0.7 - $1.46 $11,989 - $25,006	-17,128 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$1.26 - $2.23 $4,368 - $7,731	-3,467 Reduced 16.83%	17,128 $22,000
Q1 2019 May 15, 2019	BUY	$2.02 - $3.22 $17,060 - $27,196	8,446 Added 69.52%	20,595 $43,000
Q4 2018 Feb 14, 2019	SELL	$2.1 - $3.21 $28,818 - $44,050	-13,723 Reduced 53.04%	12,149 $26,000
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $5,908 - $12,604	2,626 Added 11.3%	25,872 $91,000
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $53,542 - $101,835	-20,997 Reduced 47.46%	23,246 $81,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $68,761 - $110,999	19,646 Added 79.87%	44,243 $195,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $5.65 $110,686 - $138,973	24,597	24,597 $129,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.